Sign in

CIK 0001655923 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Alpha Cognition Inc.

Sign in to watch
Ticker
ACOG
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(858) 344-4375
Business address
1452 HUGHES RD., STE. 200, GRAPEVINE, TX, 76051
Former names
Neurodyn Cognition Inc.
  1. 4 Open-market buy 10% owner bought 20,082 shares at an average $5.41 ($108,631)
  2. 4 Open-market buy 10% owner bought 4,575 shares at an average $5.73 ($26,214)
  3. 4 Open-market buy 10% owner bought 1,331 shares at $5.78 ($7,696)
  4. 4 Open-market buy 10% owner bought 13,066 shares at an average $5.79 ($75,703)
  5. 4 Open-market buy 10% owner bought 4,079 shares at an average $5.82 ($23,760)
  6. 4 Open-market buy 10% owner bought 66,818 shares at an average $5.80 ($387,622)
  7. 4 Open-market buy 10% owner bought 71,411 shares at an average $5.76 ($411,624)
  8. 4 Open-market buy 10% owner bought 4,228 shares at an average $5.99 ($25,328)
  9. 4 Open-market buy 10% owner bought 171,410 shares at an average $5.86 ($1,003,958)
  10. 3/A Insider 3/A
  11. 3 Insider Initial Statement of Ownership
  12. 4 Grant or award Director acquired 7,241 shares (grant or award)
  13. 4 Grant or award Director acquired 7,241 shares (grant or award)
  14. 4 Grant or award Director acquired 7,241 shares (grant or award)
  15. 4 Grant or award Director acquired 7,241 shares (grant or award)
  16. 4 Grant or award Director acquired 7,241 shares (grant or award)
  17. 4 Grant or award Chief Executive Officer acquired 190,549 shares (grant or award)
  18. 4 Grant or award Chief Operating Officer acquired 137,195 shares (grant or award)
  19. 4 Grant or award VP Finance and Accounting acquired 20,579 shares (grant or award)
  20. 4 Open-market buy Director bought 15,000 shares at $8.49 ($127,328)

Page 2 of 4 · 62 filings